Categories: News

Vistin Pharma ASA: Invitation to Q4 2021 conference call

Oslo, Norway, 8 February 2022

Vistin Pharma ASA will release its fourth quarter 2021 results on Thursday 17th of February 2022. Vistin Pharma will host a conference call for all shareholders and interested parties on Thursday 17th of February at 08:30 CET. There will be a Q&A session following the management discussion.

The conference call will be held in English.

The fourth quarter conference call will be available via web and audio through the following access points:

Telephone conference:
Confirmation Code:…….. 7590346
International dial-In:…….. +44 (0) 2071 928338
Norway, Oslo:……………. +47 21563015
United States, New York: +1 6467413167

Webcast:
https://edge.media-server.com/mmc/p/jb9o62eq

*****

For further information, please contact:

Alexander Karlsen
CFO
+47 97053621
alexander.karlsen@vistin.com

Staff

Recent Posts

HUTCHMED Announces US$608 million Divestment of Non-Core Joint Venture

— HUTCHMED continues to deliver on its strategy outlined in November 2022 to create value, prioritize…

2 hours ago

Bionano Announces Amendment to Senior Secured Convertible Debentures in Debt Restructuring that Improves Cash Runway

Provides financial flexibility by reducing near-term debt maturities, deferring principal redemption payment, and reducing near-term…

2 hours ago

Stem Health Plus Revolutionizes Skin Regeneration with Advanced Stem Cell Skin Graft Technology

Innovative Solutions Transform Treatment for Burn Victims, Chronic Wounds, and Scar ReductionCHICAGO, Dec. 31, 2024…

2 hours ago

Hamershlag Private Capital Management Limited Makes $150 Million Venture Structured Investment in Patho Care, LLC via PathoCare Holdings, Inc.

HOUSTON--(BUSINESS WIRE)--Hamershlag Private Capital Management Limited (HPCM), a leading health technology investment firm, has announced…

11 hours ago

Hamershlag Private Capital Markets Limited Makes $150 Million Venture Structured Investment in Patho Care, LLC via PathoCare Holdings, Inc.

HOUSTON--(BUSINESS WIRE)--Hamershlag Private Capital Management Limited (HPCM), a leading health technology investment firm, has announced…

14 hours ago